{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12907775",
  "DateCompleted": {
    "Year": "2003",
    "Month": "08",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1095-9203",
      "JournalIssue": {
        "Volume": "301",
        "Issue": "5634",
        "PubDate": {
          "Year": "2003",
          "Month": "Aug",
          "Day": "08"
        }
      },
      "Title": "Science (New York, N.Y.)",
      "ISOAbbreviation": "Science"
    },
    "ArticleTitle": "Neuroscience. Depression drugs' powers may rest on new neurons.",
    "Pagination": {
      "StartPage": "757",
      "MedlinePgn": "757"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Vogel",
        "ForeName": "Gretchen",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Comment",
      "News"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Science",
    "NlmUniqueID": "0404511",
    "ISSNLinking": "0036-8075"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents, Second-Generation"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents, Tricyclic"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Serotonin"
    },
    {
      "RegistryNumber": "01K63SUP8D",
      "NameOfSubstance": "Fluoxetine"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Science. 2003 Aug 8;301(5634):805-9",
      "PMID": "12907793"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antidepressive Agents, Second-Generation"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antidepressive Agents, Tricyclic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Division"
    },
    {
      "QualifierName": [
        "drug therapy",
        "pathology",
        "physiopathology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "pathology",
        "physiopathology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Fluoxetine"
    },
    {
      "QualifierName": [
        "cytology",
        "drug effects",
        "physiology",
        "physiopathology"
      ],
      "DescriptorName": "Hippocampus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Knockout"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Neurons"
    },
    {
      "QualifierName": [
        "genetics",
        "physiology"
      ],
      "DescriptorName": "Receptors, Serotonin"
    }
  ]
}